Dr Abusnina is a data scientist at Boehringer Ingelheim Digital lab (BI X) where he and his colleagues are building the next generation of scientist-trusted intelligent biopharmaceutical processes. Before he joined BI X he worked for about two years as a senior associate in Artificial Intelligence and Analytics group at Cognizant technology solutions. Dr. Abusnina spent fours years in the chemical industry working for Evonik Industries where he also did his doctorate internship in data driven modelling. He holds engineering doctorate degree from the university of York – UK in Large Scale Complex IT Systems, and MSc in smart systems and Technology from University of Bournemouth - UK.
Francesco Amorosi has a degree in mechanical engineering and a PhD in quality engineering. Francesco has 20 years of experience in managing international projects of process validation & equipment qualification. In 2004 he became partner of PQE and is the vice president of business development.
Born in 1955 (Carmagnola, Italy), Laurea Degree at the University of Torino (Italy) in 1979. Post-Laurea work at the Laboratory of Organic Synthesis, University of Gent (Belgium) with Prof. Pierre De Clercq. Full Professor of Organic Chemistry at the Università del Piemonte Orientale, Department of Pharmaceutical Sciences, Novara (Italy), since 2000.
Research activity in his laboratories takes inspiration from plant natural products to address problems in various realms of biomedical investigation, from pharmacology and nutrition (new drug leads and health-promoting dietary ingredients) to organic/medicinal chemistry (new synthetic methodologies and optimization of natural product drug leads) and cell biology (novel mechanisms of activity). Author of over 350 peer-reviewed articles and 15 book chapters on the chemistry and bioactivity of plant natural products. Editor-in-Chief of the journal Fitoterapia and member of the Advisory Board of the PharmaNutrition, Natural Products Reports, Acta Pharmaceutica Sinica B, and Progress in the Chemistry of Organic Natural Products. Recipient of the Rhône-Poulenc Rorer Award of the Phytochemical Society of Europe (1991), the Medaglia Quilico of the Società Chimica Italiana (2009) and the Bruker Prize of the Phytochemical Society of Europe in 2014 for his studies on bioactive natural products.
Dr. Caroline Bauer is a Pharmaceutical Development Manager at the Lonza Ploermel site in France.
Prior to joining Lonza, she worked in a biotechnology company in the field of innovative drug delivery systems. Dr. Caroline Bauer earned degrees in chemistry (PhD), a European Master in chemistry and formulation science from the University of Regensburg (Germany), and a doctorate in physical chemistry from Montpellier University (France). In her current role she deals with pharmaceutical development projects ranging from early to late stage development for NCE , lifecycle management as well as generic drug development.
Dominique Bauert started his professional career in 2008 as Key Account Manager in a mechanical engineering company before he moved in the Medical Device branch in 2013. For his role as Regional Manager Asia Pacific, he lived 3 years in Singapore and was responsible for the company’s Representative Office, the market development as well as the mid-term and long-term growth strategy of the company. In the year 2016, Dominique Bauert joined SCHOTT as Global Business Development Manager for the segment Cartridges and moved for this role to St. Gallen, Switzerland. After one year, he took over the role of Head of Business Development for Cartridges. He is playing a key role in the market launch of cartriQTM (Ready-to-Use cartridges) and is the leading person for the market development for bulk and RTU cartridges.
Dominique has more than 10 years experience in sales, innovation and product management.
He is a professional speaker at many conferences and seminars on topics related to parenteral primary packaging and drug delivery devices.
He holds a Diplom-Ingenieur in Mechanical Engineering as well as a Master of Science.
Vincent is leading the Pharmaceutical Technology Transfer and Innovative Technology Introduction Department at Lonza DFDS LPB, France. He brings more than 15 years of experience in both chemical and pharmaceutical industry with various positions such as Project Engineer, Project Manager and Technical Services Manager.
Promoter of the QbD approach as an efficient way to lead complex projects with reducing risks, Vincent is managing the process set-up and transfer of multiple dosage forms from clinical to commercial, as well as engineering innovative technologies to expand Dosage Forms portfolio.
Vincent holds a General Engineering degree from CESI in Paris, completed by a Master degree in Project Management from the University of Mulhouse, a Master degree in Governance from the Ecole Nationale des Ponts et Chaussées & French Institute of Urbanism in Paris, and finally an Executive Management Program from Vlerick Business School in Belgium.
Director R&D, Aker BioMarine. PhD, University of Oslo, and former Fulbright Scholar, Massachusetts General Hospital/Harvard Medical School. Research interests include nutritional and lifestyle factors associated with human health outcomes, with a particular focus on polyunsaturated long-chain omega-3 fatty acids.
Mikael Bisrat is a Sales Director in the Development Sales team at Recipharm, involved in business development with a focus on the Nordic market. Mikael, who has a Ph.D. in Pharmaceutics from Uppsala University and an EMBA from Stockholm School of Economics, has a wealth of experience in the pharmaceutical industry. He has extensive knowledge about late stage discovery, formulation development and the production of clinical trial materials.
Kevin has over 30 years' experience working in the healthcare sector, principally with pharmaceutical, biotechnology and business consultancy companies.
He has been involved in the successful divestment and acquisition of many businesses, acting as advisor to major pharmaceutical and biotechnology companies. Successful transactions he led whilst at PharmaVentures included the sale of 2 Sanofi research sites to Covance, divesting Dow Pharmaceuticals API manufacturing division to Dr Reddy's Ltd, the sale of manufacturing businesses from UCB to Aesica, the divestment of Merck's research site in Newhouse, Scotland to BioCity and in 2012 the divestment of Zentiva's (a Sanofi Group Company) Hlohovec plant to Wood Pharma Holding. In the last five years his divestments have resulted in the successful transfer of over 3,700 jobs to new owners and significant value creation for clients. Kevin also has extensive experience in licensing of research compounds, technologies, IP and pharmaceutical products. During his career Kevin has held senior positions in pharmaceutical research, alliance management, business development and transactions. He has worked at Hoechst (Sanofi) , Quintiles, Roche Pharmaceuticals, Inpharmatica and PharmaVentures, where until August 2012 he was Head of Transactions.
Brandon Boyd is currently Industry Strategist for Generics within the Life Sciences business of Clarivate Analytics. In this role, he manages strategic business initiatives and partnerships that accelerate the pace of drug development in the generics finished dose and active pharmaceutical ingredient (API) sectors. Previously, Brandon was Segment Lead for Generics, with responsibility for management and development of the Newport product suite, Clarivate’s API and generic finished dose intelligence solution.
Prior to joining Clarivate Analytics, Brandon served eight years in positions of increasing responsibility at Teva Pharmaceuticals. His last role was Head of Market Insights for US Generics, where he led a team of research and analytics professionals charged with delivering business performance reporting and market intelligence to commercial and corporate leadership. Also, during his tenure at Teva, Brandon served as strategic associate/chief-of-staff to the President of the Americas region, as well as a pipeline portfolio management and new product forecasting analyst.
Brandon earned his MBA from the Pennsylvania State University and his Bachelor of Science degree in Economics from the University of Pittsburgh.
Lynne Byers has gained more than 35 years’ of extensive pharmaceutical manufacturing management and QA experience working for three major international pharmaceutical manufacturers, culminating in the role of Global Head (VP) of External Supply Operations QA for Novartis in Switzerland. In addition, she worked as Head of Inspectorate and Licensing for the MHRA from 2004-2006. She joined NSF in 2017. Ms. Byers has broad experience in manufacturing management and QA of a wide range of sterile and non-sterile dosage forms, and is fully conversant with current EU and FDA GMP regulations and requirements. She has extensive experience in international QA auditing of a wide range of pharmaceutical manufacturers who are suppliers to the pharmaceutical industry worldwide. She also has extensive experience in managing QA teams in country affiliates. Ms. Byers is eligible to act as a Qualified Person and was a QP assessor on behalf of the Royal Society of Chemistry from 1999 to 2004. During her tenure with the MHRA she was responsible for agreeing to QPs being named and removed from manufacturing authorizations.
Virginie Caprasse is responsible for providing technical support and service to numerous healthcare customers in Europe. Her responsibilities also include new formulation and application development, claims testing and validation.
Experience and Expertise:
Virginie provides formulation and technical expertise across Pharmaceuticals and Medical Device topical applications. She has played a pivotal role in several product launches including the Dow Corning® Scar and Stretch Mark Management package. Prior to being appointed to her current position, Virginie supported various Beauty Care product developments.
Virginie joined Dow Corning in 1998 and is now a Formulation Specialist, TS&D with the Dow Pharmaceutical Solutions team.
Virginie earned a bachelor’s degree in chemistry and a master’s degree in dermo-cosmetics from Université Libre de Bruxelles, Belgium.
Reiner Christensen has more than 20 years of international experience in the pharma & OTC industry – in General Management and Sales & Marketing. He holds a Diploma in Industrial Engineering & Management and an Executive MBA from Ashridge in the UK. His work has lead him to many different regions including the CIS/CEE, Latin American, Asian and European regions and he is still a keen traveller and enjoys learning about different cultures. Reiner is the CEO of Chameleon Pharma Consulting and is delighted to share some insights with you. On a more personal level, Reiner has a passion for French and Thai cuisine and enjoys cooking with his two daughters.
Medical Doctor with vast experience in multiple fields such as medical practice, Spanish medicines agency, Pharmaceutical Industry and science and health consultancy. In 2011 she founded Azierta which has experienced a remarkable growth with nearly 90 employees providing scientific expert support services worldwide.
Fernando Diez is Scientific Business Development Manager for ACG – the leading global manufacturer of empty hard capsules. He has an MBA and degree in chemistry. His work mission is creating new business opportunities outside of the formal review/tender process and the relation with external researching institutes and R&D centres. He has long experience in pharmaceutical industry and worked with renowned multi-national companies in the industry.
Mr. Diver has been in the Pharma industry for nearly 30 years, having served technical and commercial roles for both innovator companies and CDMOs. Currently, he is the Director, Business Development in the Lonza where he has been collectively for over 10 years. He has experience in the supply of both small and large molecules, and has had held roles in strategic procurement, strategic sales, and business development. Mr. Diver is currently the 3rd Vice President of the DCAT Organization, and is a member of the Chemical and Biomolecular Engineering Advisory Council at Lehigh University.
Dr. Polina Dombure runs her own GxP consultancy providing support and advice to her Clients on regulatory affairs, drug safety, GMP, GDP, market access and P&R strategies. Dr. Dombure has worked in this field for over 18 years, with prior experience in manufacturing of finished medicinal products, quality assurance, regulatory affairs and pharmacovigilance. Years of experience have allowed for developing a strategic approach to complex regulatory issues allowing for regulatory product management over the whole life cycle. Dr. Dombure has created a CRO business model, which today is the only one providing full-scale GxP, regulatory, pharmacovigilance, and training and digitalisation services providing coverage of CIS countries with European level quality.
Dr. Duncan began his career at the Dutch Institute for Atomic & Molecular Physics in Amsterdam. He moved into industry holding Product & Application Development closure integrity testing, lyo chamber moisture mapping, and automated media fill inspection.positions. Currently at Lighthouse since 2003, Dr. Duncan is responsible for developing applications for process monitoring and finished product inspection. These include using headspace analysis for 100% container closure integrity testing, lyo chamber moisture mapping, and automated media fill inspection.
Susana Ecenarro is the Scientific Business Development Director of Qualicaps Europe.
She holds a MBA and a bachelor degree in Pharmacy. Prior to Qualicaps she worked
for the German pharma company Schering AG for 18 years in different quality
positions and covering several functions as analytical development, process
validations, technology transfers, operation excellence projects, etc., followed by 5
years of experience leading an analytical R&D unit of a Bayer Healthcare facility.
Her main work mission in Qualicaps® is to support R&D centers within the
pharmaceutical industry in new drug developments by providing the scientific and
technical expertise they might need, as well as promoting collaborations with European
universities and other third parties focusing on the application of state-of-the-art
Dr Amina Faham, Senior Global Manager, R&D Pharma, The DOW Chemical Company. Amina earned a Ph.D. degree in Pharmaceutical Sciences from school of Pharmacy, University de la Mediterranée France. Amina has over 15years of pharma industry experience in oral solid dosage forms with emphasis on modified drug release technologies, process development and optimization, and project management with companies including Ethypharm, Pfizer Pharmaceuticals and Colorcon, all based in North America region. Amina has a strong background and experience of fundamental areas which apply to drug delivery, risk management, control strategy and pharmaceutical market analysis. She has strong knowledge on regulatory affairs support of submissions and on-going regulatory compliance for product development process. She joined DOW Europe in Switzerland in 2011, as a pharmaceutical application specialist to drive and support the pharma business growth in Europe Middle East and Africa, and then moved into a global leadership role in Pharma R&D organization. Since May 2018, Amina’s new role is to head the Global Pharma Application Development & Innovation within Nutrition & Health Business. One of Amina’s main responsibilities is to use her pharmaceutical technical and scientific expertise to closely connect to the innovation needs of the pharmaceutical industry. Amina is a member ofthe DOW Swiss Commercial Excellence team and a member of the DOW Women Innovation Network Europe Middle East Africa and India Steering Committee. Amina is also a lecturer at Zurich Federal Institute of Technology (ETH) and an executive board member of the International Pharmaceutical Excipients Council (IPEC) in Europe.
Senior Product Manager for Pharma Blister Systems & Sachet Laminates working for Amcor Flexibles Europe, Middle East & Africa. I am a PhD and Post Doc in Polymer Applied Chemistry having worked in R&D and Marketing within the Flexibles Packaging industry during the past 18 years.
Mrs. Gillet has a biochemistry background and began her career at Sterigenics up to 10 years ago as Quality Manager for the Belgian plant, managing the quality system, the QC team as well as the validation team. She was in charge to review and approve validation protocols and reports. She acted as the main contact during customers and regulatory inspections (FDA, European Authorities etc.). Mrs. Gillet also gained ten years of experience in Medical Device industry (wound dressings) in R&D, Quality, and consultancy. She also worked for about two years in Pharmaceutical industry (Manufacturing of terminally sterilized hormonal Intra Uterine device) in quality department, equipment and process validation where she was SME in Sterilization.
As a SteriPro® Director for 2.5 years, Mrs. Gillet currently leads ethylene oxide sterilization projects in different Sterigenics plants and is supporting the plants as technical expert with pharmaceutical project responsibilities
Thomas Grinnan, Senior Global Commercial
Director, Healthcare, Silgan Dispensing Systems, has worked in the pharmaceutical industry
for more than 25 years as an executive, innovator, consultant and business development
specialist. A biologist, he began his career in the Healthcare practice of Markowitz &
McNaughton, Inc., a strategy consulting firm, working closely with pharmaceutical and
medical device companies. After receiving his MBA, he began a long career with Mebane
Packaging, a healthcare packaging company, and its antecedents Westvaco and then
MeadWestvaco. At MeadWestvaco, Tom held various leadership roles in the Patient
Adherence and Healthcare Packaging business, leading European sales & marketing, global
clinical trial packaging, as well as business development and innovation. After
MeadWestvaco (subsequently renamed Westrock), Tom joined Silgan Dispensing Systems, a
spin-off specializing in the supply of pump and liquid dispensing solutions. Silgan Dispensing
Systems is a leading partner to the pharmaceutical industry, supplying pumps and dispensing
systems for nasal, ophthalmic, topical, oral and otic applications. Tom received his BA from
the University of Virginia and his MBA from the University of North Carolina, Chapel Hill.
Roman Ivanov is Vice President, R&D, of biotechnology company BIOCAD. He is responsible for product development and regulatory affairs. Prior to joining BIOCAD, Roman conducted scientific research in the field of molecular immunology at the Hematology Department of Utrecht University Medical Centre in the Netherlands. He is an author of multiple scientific publications in international peer-reviewed journals. Roman was responsible for development of the first rituximab, trastuzumab and bevacizumab biosimilars marketed in Russia. Currently he supervises clinical development of several other biosimilars and next-in-class biologics as well as non-clinical studies of multiple innovative products developed by BIOCAD.
Frédéric Jailloux has more than 20 years of experience in Global Procurement, Supply chain and performance management, mostly in the Pharmaceutical and Packaging sectors. He worked 13 years in Procurement for GSK Pharma where he was a former Global Procurement Director. He then lead a program to switch diverse Consumer Healthcare’s Products’ packaging to Child Resistant Senior Friendly ones across a network of 30+ contractors around the world. In 2015, Frédéric Jailloux created VAL-U Advisory, a consulting company based in Belgium but acting internationally to improve his Clients’ profitability and growth. Negotiating and contracting the sourcing of equipment and software for serialization on behalf of a CMO, reorganizing and improving the supply chain of a site, guiding his Clients to raise efficiency are among his recent successes. He’s been also a speaker at different conferences to help Companies to better understand and respond to Pharma requirements and expectations.
Dr. Maurits Janssen is senior Director, Head of Commercial Development for the Active Pharmaceutical Ingredient (API) Business Unit at Lonza.
He earned his Ph.D. in organic chemistry from Utrecht University in The Netherlands (1996) and subsequently fulfilled several functions with increasing responsibility in consulting, marketing & sales and research & development.
Dr. Janssen has over 20 year experience in chemical and pharmaceutical industry and over 15 years in the custom manufacturing of active pharmaceutical ingredients. Throughout his career, Mr. Janssen worked across a broad portfolio of technologies in cGMP Chemical & Biological custom manufacturing from early stage to late phase/commercial and gained significant experience with Highly Potent Active Pharmaceutical Ingredients (HPAPI).
Martin Junginger is Head of Global Product Management Pharma & Business Development Gelatine at GELITA AG in Eberbach/ Germany. He is responsible for the portfolio of pharma gelatine, mainly for soft capsules with different dissolution and cross-linking properties. Besides Mr. Junginger is in charge for the Global Innovation Process to establish, manage and report innovation projects at GELITA. Prior to joining GELITA in 2017, Mr. Junginger was Head of Product Development for Modern Wound Care dressings for the treatment of acute and chronically wounds. In the years before he was responsible for process development and establishing of pilot and production plants for medical devices. Mr. Junginger holds a Dipl. Ing. (M.Sc.) degree in chemical engineering from the University of Stuttgart, Germany.
After finishing his first clinical manufacturing facility in 1995, Nick subsequently had head responsibilities for three other clinical biologic manufacturing facilities in Australia. In 2007 he relocated to Singapore as Principal Consultant, and later General Manager, of an engineering firm active throughout ASEAN countries and China serving pharma and biotech clients. Prior to joining CMAB, Nick was VP of Facilities and Engineering for JHL Biotech where he managed a capital expenditure program of US$80m over three years that delivered two GMP pilot plants and a commercial facility with a modular KUBio® building for the manufacture of cell culture products. Nick holds a Bachelor degree in Chemical Engineering and a Doctorate of Philosophy from the University of Adelaide. He is a Charted Engineer, Member of the Institution of Chemical Engineers, and Member of ISPE.
Dr. Henning Kuhz is the Project Manager for Biopharma at Dr. Paul Lohmann GmbH KG. As part of the project team he is responsible for the development of the biopharmaceutical business unit. He studied biochemistry at the university of Braunschweig in Germany.After finishing his Ph. D. he was assigned to various project management functions.
Dr. Sanjeev Kulkarni is vice president, R&D and new technology Bilcare India. He is passionate for creating innovative products. He has worked as head of innovation with companies like ACG and Essel. He has patented, developed & commercialized multiple pharmaceutical packaging products. He established and maintained the innovation lab at Bilcare.
With a Master in Bioengineering, Morgan rapidly developed a special interest in organic chemistry and natural medicines. During the last 3 years, Morgan developed a profound experience in developing multiple customer solutions using the advanced science of Lonza’s specialty ingredients and Capsugel’s capsule technology platforms.
With a Master’s Degree in Chemical and Process Engineering at the University of Padua, Martina Largoni boasts a vast knowledge in chemistry, physics, informatics, mathematics and statistics. She worked on the optimization of pharmaceutical processes, engineering the monitoring and control of the quality of the product.She entered Stevanato Group in 2015 as Technical and Quality Assurance Front End for Ompi, gaining experience in the glass primary packaging and injectable delivery fields.Now she is Product Specialist EZ-fill Vials and Cartridges.
Dr. Enrique Lozano Diz has been responsible for Business Development at B&W Tek for the past 6 years with a focus on up-and-coming markets of South America and Africa. Dr. Lozano Diz has been in the spectroscopy industry for 14 years and has over 25 scientific papers and 2 patents focused on spectroscopy applications. He received his Ph.D in Chemistry from the University of Neuchatel after completing his Master's in inorganic chemisty at the University of Sevilla.
Working since almost 2 decades in the Packaging Industry supplying to Pharma customers in an International Level. I was responsible for Sales, Marketing, PM and Innovation.
After graduating as Engineer in Chemistry from Montpellier, Nicolas completed his PhD in organic and polymer sciences followed by a postdoctoral scholarship on synthesis of copolymers as specific transportation vector for drugs. Nicolas started his industrial career in the ink jet printing before joining Capsugel as research engineer and evolved in different departments from formulation, to Licaps production and now as Business development manager. During his career Nicolas wrote several articles and filed patents in different domains related to capsules.
Engineer and PhD in science of matter. Loïc Marchin is an innovative entrepreneur for a dozen years, Loïc Marchin has created Pylote
in 2009 with the ambition to provide to the markets of the industrial innovations, cleaner, greener, safer.
Jim Miller is the founder and president of PharmSource. A preeminent expert in bio/pharmaceutical outsourcing, Jim established and presides over the pharmaceutical outsourcing industry’s premier collection of market intelligence services, including the PharmSource Lead Sheet and PharmSource STRATEGIC ADVANTAGE database services and the monthly briefing, Bio/Pharmaceutical Outsourcing Report. Jim has consulted to many of the top bio/pharmaceutical companies and contract research and manufacturing organizations. He previously served as a consultant in corporate strategy with the Boston Consulting Group and as an executive with several healthcare companies. He holds an M.B.A. degree from the Stanford University Graduate School of Business.
Dr. Greg Moakes, a physical chemist by training, leads the Field Development team for the Celanese Corporation medical polymers business. Greg and his team use medical and implant grade products to create technical solutions for the medical device and pharmaceutical industries. Greg received undergraduate degrees in Chemistry from the University of Leeds in the UK. He also holds a Ph.D. in Electroanalytical Chemistry from the Georgia Institute of Technology, and a Master’s in Business Administration from Southern Methodist University.
Elise Mous joined Capua BioServices in 2015 as Director Sales & Marketing / Business Development to further strengthen and develop Capua BioServices’ positioning as a microbial CDMO in the pharma and food market. She started her career at DSM in 2004, followed by Patheon in 2014, and during the past 8 years built up her international business development experience in the field of custom research, development and manufacturing services. Mrs. Mous holds an MSc degree in managerial sciences next to a BSc degree in chemistry/biotechnology.
Emmanuel Mujuru is Chairman of the Board of The Federation of African Pharmaceutical Manufacturers Associations (FAPMA). A qualified Pharmacist and Entrepreneur with a passion for the development of local pharmaceutical production not only in Zimbabwe but in Africa in general. Emmanuel has been active in the pharmaceutical industry for the past 20 years during which he gained extensive experience in pharmaceutical production, research and development, quality assurance and marketing and distribution.
Guenter Nadler is the Director of Business Development in Aptar Pharma’s Consumer Health Care division. Within Aptar, Guenter plays an integral role as part of their Global Market Development organization, heading strategy and innovation for the Cough & Cold business. He has 18 years of broad experience in drug delivery, including various technical and commercial roles. Guenter graduated with a degree in Business Administration and Mechanical Engineering, and is recognized as one of the leading experts in cough & cold treatment options worldwide.
Degree in Environmental Sciences, Master in Environmental Management in Business. 8 years of experience in Sustainable Forest Management, Chain of Custody certification, implementation of responsible Supply Chains and development of Corporate Social Responsibility policies. Expert in advice on how brands, retailers and organizations from different sectors can contribute to the Sustainable Development Goals 2030. Presentation and development of projects at national and international level aimed at the promotion of forest sustainability, safe supply chains, and responsible procurement of forest-based products. Representation of PEFC in technical conferences, conferences, round tables, fairs, bilateral meetings.
Ara Ohanian is chief executive officer of Systech, the pharmaceutical serialisation pioneer and global leader in product safety, and consumer and brand protection. Ara joined Systech in 2018 to lead the company into its next stage of robust growth. Building on the core Systech mission of ensuring a secure supply chain, Ara aims to provide clients with authentic, safe products from the factory floor to their consumer’s hands.
Before joining Systech, Ara led Unite US, a care coordination platform bridging healthcare and social services. Prior to Unite US, he served as senior vice president and general manager for Infor, the world’s third largest enterprise software company. At Infor, he led the statutory compliance solution supporting Infor ERPs across 91 global markets. Earlier in his career, Ara was founder and CEO of Certpoint Systems, a Learning Management System leader that was acquired by Infor in April 2013.
Ara brings operational as well as substantial software and healthcare experience to Systech and will play a vital role in the expansion of its global presence and market solutions. He holds a B.A. in business communications from Baruch College, City University of New York.
Business Development Manager Product Partnering Sterile Pharmaceuticals Region Europe, LAM, Africa & Asia
Key Accounts & Business Development Manager Product Partnering Sterile Pharmaceuticals Central Europe
Mr. Zhu Renzong graduated from Peking University in 2013 with a master's degree in chemical biology and a double bachelor's degree in economics. He is currently the deputy secretary of Sub-chamber of China Chamber of Commerce for Import and Export of Medicines and Health Products.
He has been engaged in market research, business coordination and trade promotion of the API industry for five years. And participated in research on the development of the pharmaceutical industry by the Ministry of Commerce, National Development and Reform Commission, Ministry of Industry and Information Technology and CFDA. He has published many research articles in professional newspapers and magazines such as "Fine and Special Chemicals" and "Medicine Economic Reporter". He has a deep understanding and research on the commodities, markets, policies and regulations of the API industry.
With legal backgrounds Andrea is a regulatory policies and EU public affairs senior advisor, with focus on issues related to application of technical regulations and systems of evaluation and certification in different Sectors. He assisted companies and Sector associations and federations in issues related to development of new EU technical regulations and in complaint procedures before EU Commission for lack of application of EU laws by members Countries.
Andrea developed analysis on pharma supply chain and on third party voluntary systems for evaluation of information on APIs and Intermediates and relevant manufacturers.
CODEMA PHARMA Rating Program Director since July 2017.
Karin Schrooten holds a master of science in chemical engineering from KULeuven, University of Leuven, in Belgium and has been working for Capsugel/Lonza for over 25 years. Through different positions with increasing responsibilities within the company, she built experience in manufacturing, customer service, sales and quality. In her current role as Senior Director Global Quality, she oversees the Quality Assurance, Quality Control & Compliance and Regulatory Affairs organizations in the eight capsule production plants. As part of the Lonza group, Karin is currently based in Basel, Switzerland.
Graduated from Nanjing Xiaozhuang University in June,2013.Majored in Analytical Chemistry.After graduation,he entered in medicine device company and engaged in the development.He entered in Lefancaps and took charge of capsule testing and evaluation work from April 2016.Since June,2017.he has been worked as product engineer and communicating with customers on various technical issues.
Mr. Ravleen Singh Khurana has completed M.pharm in 1994 and Post graduate in management and has a dynamic personality with wide knowledge in the development of many organic and inorganic products in R&D.
He started Nitika Pharmaceutical Specialities Pvt.Ltd in 1991 as Excipient Manufacturing Company at the mere age of 19 years and has designed and framed this company with a great vision, mission, quality policy & corporate philosophy . The Company is manufacturing high quality excipients and exporting to 90+ countries with 1000 + buyers across the globe in regulated and emerging market.
He has participated along with his techno marketing team in many international pharma and food expo like CPhI worldwide, Chemex, vitafoods, Asia healthcare etc.
Besides this the list of Awards and Honors include, “Leading excipient award” by UBM in 2005, “Star Export House” by Government on India 2015and many more. Above all awards is the most prestigious National Award, which he received recently by MSME, Government of India, chaired by PM Narendra Modiji for Outstanding Entrepreneurship.
Education: Chemical engineer, Ph.D. – Economics and Management.
Employment: technical position in KAU?UK, a.s. Kralupy(1982-1995), then Development Director and Member of the Board of UNIPETROL, a.s. Prague (1995-2001), then Managing Director of refineries KORAMO, a.s. Kolin (2001-2002) and CESKA RAFINERSKA, a.s. Litvínov/Kralupy nad Vltavou (2002-2011). Advisor in consulting company ENA (2012). Project manager and advisor in NIS (2012-2016). Currently hosting professor at University of Chemical Technology, Prague (VSCHT Praha) and Director of Association of Chemical Industry of the Czech Republic.
Publishing activities: Co-author of 8 patents in polymer technology; number of articles in area of polymer technology, refining, bio-fuels, petrochemical and natural gas industry development and economics (1982-2018), number of international and domestic conferences: presentations in area of refining, bio-fuels, petrochemical and natural gas industry development, benchmarking and competitiveness; co-author of 5 books on Project decision making and management, Strategic planning.
Mr. Hiroaki Sugasawa is the director of the overseas business development department at Mitsui Chemicals Japan. He has lead the development of many path breaking products related to food and pharma packaging. He speaks five languages.
Julie D. Suman, R.Ph., Ph.D is the Founder of Next Breath, an Aptar Pharma business, and serves as its President. Dr. Suman holds a B.S. in Pharmacy from Duquesne University (1996) and a Ph.D. in Pharmaceutical Sciences from the University of Maryland, Baltimore (2002). She is a co-editor for Respiratory Drug Delivery Proceedings, an international symposium, and an Affiliate Assistant Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University. Dr. Suman is the Past-Chair of the AAPS Inhalation Technology Focus Group. She is also a licensed Maryland pharmacist. Dr. Suman has published her research in peer-reviewed journals and has been presented during podium sessions at international meetings, the FDA Visiting Professor Lecture Series and has been an invited speaker at ANVISA in Brazil. Dr. Suman’s doctoral research, which focused on the relationship between in vitro tests for nasal sprays and in vivo deposition, has been recognized for excellence by a research award presented at the International Society for Aerosols in Medicine, 2001.
Dan-Ola Svensson has over 30 years of experience in the world of thermoplastics. He spent the early years as quality engineer with a major injection molding company, serving the automotive industry and laid the foundation to his profound interest for quality management systems, leadership for quality and quality improvements. While keeping his initial interest area, he moved further into the world of compounding of standard and engineering plastics, driving developments within the quality- and laboratory management systems. Furthermore, innovation became a key area leading to special raw material- and compound solutions. He joined Clariant in 1997. After a position within quality- and laboratory management, in 1999 Dan-Ola became technical manager for the Malmoe/Swedish masterbatch manufacturing site, focusing on technical- and regulatory innovations of processes, products and services. In 2010, in relation to Clariant implementing a dedicated medical- and healthcare organization and the brand name of Mevopur, he became regional technical manager for Europe within segment Healthcare Polymer Solutions. Within Clariant Plastics & Coatings, BU Masterbatches provides color - and functional additive masterbatches and compounds for the Medical & Pharmaceutical industry.
Since obtaining his Ph.D. in the ion optics of mass spectrometers at the University of Manchester Institute of Science and Technology (UMIST) in England, Lester Taylor has worked in the field of mass spectrometry both in the areas of instrumentation and applications development. Subsequently Lester joined Burroughs Wellcome Co. in Research Triangle Park, NC, where he held positions of increasing responsibility in Drug Discovery and became Assistant Director in the Organic Chemistry Division. During this time he was responsible for applying mass spectrometry, NMR and optical spectroscopy methodologies to a wide range of analytical challenges in pharmaceutical drug discovery and development. More recently, he joined Thermo Fisher as the Marketing Director for life sciences mass spectrometry. In 2009, he joined Agilent technologies, Santa Clara, California as the Director of LC/MS Product Marketing, until May 2014 when he took on the role of Pharma market manager.
Jegadeesh holds a Ph.D in Chemical Technology from the Department of Chemical Technology, University of Mumbai, India, post-doctoral fellowship from the Institute National Polytechnic Toulouse, France and an Executive Post Graduate Diploma in Management from the Indian Institute of Management, Kozhikode, India. He has over 16 years of research and development experience with chemicals, catalysis and API/NCEs. As the Vice President and Head of Chemical Development vertical at Syngene, Jegadeesh is responsible for the development and manufacture of investigational API/NCEs, performance and specialty materials and therapeutic oligo nucleotides.
Hitesh comes from a humble background and started his career as Medical Representative in India. He worked with companies like Cadila Laboratories, Ranbaxy, and Novartis in India.
Hitesh moved to Africa in 2006 and since then he has worked in Indian and African pharmaceuticals companies, predominantly in East Africa region.
Since 2016, Hitesh is associated with an Africa focused private Equity fund - Catalyst Principal Partners. He is currently managing the 2nd largest pharmaceuticals company of Tanzania - Zenufa Laboratories Limited which is an investment of Catalyst.
He has turned around the company in these 2 years, not only in terms of revenue OR profits but contributing by employing best HR practices, observing GMP in production thus offering best quality Medicines produced by a Tanzanian company. He strongly believes that we may not be the biggest but for sure, we need to be the best!
Hitesh is Director of "Federation of East Africa Pharmaceuticals Manufactures", Board Treasurer of "Tanzania association of pharmaceuticals manufacturers" & member of "Tanzania Pharmaceuticals Manufacturing Association" & "Tanzania Association of Pharmaceuticals Industries". He works closely with government agencies in Tanzania and East Africa for the promotion of local manufacturing industries and harmonization of pharmaceuticals business of East African countries. At the country level, Hitesh is known as an ardent activist for the promotion of local pharmaceuticals manufacturing industries.
Hitesh is a management graduate from India's prestigious management institute IIM- Calcutta in International Business besides a graduate in science. Hitesh is an endurance cyclist, a marathon runner, and working to be an Ironman before the age of 50.
Hitesh is staying at Dar Es Salaam-Tanzania with his wife and 16 year's old son
Mr. Kenichiro Usuda is a researcher of Advanced Business Development Division. He gained a Diploma in Engineering in 2009 and a Master Degree of Engineering in 2011 from Tokyo Institute of Technology. Since April 2011 he has been working for Mitsubishi Gas Chemical Company, Inc. and in charge of macromolecular science, especially in synthesis of polymers and material development. Since 2012 he has joined a development team of multilayer vial and pre-filled syringe for pharmaceutical drugs.
Mark van Eldijk is project manager at Ardena API & Nanomedicine Development and Manufacturing. In 2016, he joined ChemConnection, which is now part of Ardena. Mark is responsible for development and manufacture of nanomedicine products, including polymeric nanoparticles and iron oxide nanoparticles. Often these nanomedicine products consist of complex nanoparticles functionalized with biomolecules and/or APIs. Before joining Ardena, Mark was a postdoctoral research fellow at California Institute of Technology. He obtained a PhD in Bio-organic Chemistry from Radboud University Nijmegen, where he worked on the design and preparation of protein-based nanoparticles. He has published more than 20 papers in peer-reviewed journals.
Michiel Van Speybroeck is currently Head of Formulation at Ardena Drug Development & Manufacturing, where his key responsibility is to oversee activities related to formulation and process development and non-GMP manufacturing. Michiel has coordinated the development of technically very diverse formulations for a wide range of applications, including 20 liquid and solid oral dosage forms used in early-phase clinical trials. Prior to joining Ardena, he was Chief Scientific Officer at Formac Pharmaceuticals and postdoc at the Monash Institute of Pharmaceutical Sciences in Melbourne. Michiel holds a PhD in Pharmaceutical Sciences from the University of Leuven. He is (co)author of 15 original articles and a book chapter, and is a member of the editorial advisory board of the Journal of Pharmaceutical Sciences.
Lise Vanderkelen received her Ph.D. from the Faculty of Bioscience Engineering at the University of Leuven (Belgium) in 2012. She started at Nelson Labs Europe (formerly Toxikon Europe) in 2013 as study director at the Extractables & Leachables Department, focusing on Injectables and Parenterals and in 2014 she became responsible for the chemical characterization testing for the medical device industry. In 2016, she became Department Head Pharma Services at Nelson Labs Europe. The main focus of this department is identifying organic impurities in drug products as well as in use stability of drug-device combination. In 2017, the scope expanded and includes now also all microbiological testing offered at Nelson Labs Europe.
Maria Jose Villanueva current Marketing Manager Diabetes in AstraZeneca Spain, has broad experience in pharmaceutical companies in sales and marketing. Leading and implementing KAM and building high-performance sales teams in oncology as National Sales Manager. And in marketing leading crossfunctional teams with successful launches of innovative products and able to develop innovative solutions for HCPs and patients to improve Healthcare outcomes in chronic diseases with different stakeholders, maximizing the opportunity that new technologies and social media offer.
Maria José has a Veterinary degree by Complutense University (Madrid, Spain), is Master in Healthcare Management and Pharmacoeconomics by Pompeu Fabra University (Barcelona, Spain) and Advance Management Programme by ESADE Business School (Madrid, Spain).
In a career that has spanned over three decades Chris Waterhouse has provided Packaging and Supply Chain technical expertise and innovation insight to some of world’s leading Pharmaceutical, Agrochemical and Petrochemical companies.
Chris is Managing Director of iDi Pac and Chairman of the UK Packaging Society; the “Home of Packaging Professionals” which represents over 900 Packaging Professionals across the UK and Overseas. He is also the founder and Managing Director of Digi Leaflet Technologies Ltd; a hi-tech spin-off from iDi Pac Ltd.
Widely recognised as the ‘go to-guy’, Chris is much sought after across the Packaging and Supply Chain Industry and an acclaimed speaker at business conferences and industry events - well known for his technical innovations, practical insights, and leading edge thinking.
Tom Wilson is Vice President of Contract Manufacturing Operations for Pfizer Global Supply (PGS) and Pfizer CentreOne Contract Manufacturing. In this role, he serves as manufacturing liaison between the two organizations. In previous roles, Tom led Pfizer Optionality Program for PGS, as well as the Integration Team for Hospira Device Operations; oversaw management of Pfizer’s Alliance External Suppliers worldwide; and provided counsel on Pfizer’s global manufacturing strategy. He joined Pfizer in 2010 with the acquisition of Wyeth, where he was Vice President of Product Operations. Tom is a former United States Air Force Captain, serving as a Command and Control Officer. He holds a B.S. in Physics and an M.S. in Administration and Management.
Olukayode Afolabi leads DFS Africa’s Private Equity and Impact Investing activities. In his role he curates platforms such as the Deal Room, Deal Portal and Investor Roundtables to fast track the deal making process in Africa. Kayode’s expertise is in Deal Structuring, Raising Capital, Board Governance and Operational Management to turn around financially distressed or undervalued companies and maximize shareholder value. Prior to co-founding DFS Africa, Kayode worked with leading Investment Banks and Industry leaders such as UBS, HSBC, Columbia-Threadneedle and British Telecoms leading large scale revenue-generating and regulatory programs. Kayode has a Bachelor degree in Industrial Chemistry from the University of Ilorin Nigeria, and has attended several executive level courses at Harvard University and SAID Business School (University of Oxford) covering subjects such as Project Financing, Investments & Portfolio Analysis and Entrepreneurship. Kayode’s professional mission is to make a significant and sustainable impact in improving the lives of people across Africa.
Bernd Zeiss, Dipl.-Biol. studied biology, microbiology and chemistry at the University of Göttingen, Germany. He works in the Gerresheimer Centre of Excellence for prefillable syringes as Manager Technical Support. His main areas of work are investigating possible interactions between syringe components and drug as well as the evaluation of innovations like COP syringes in comparison to glass. Bernd also carries out inhouse functionality studies on prefilled syringes and prepares technical documentation for customers called "Technical Bulletins".
Laurent Zuber has a deep knowledge of the Pharma industry and of the Glass Industry since 2002. Laurent Zuber is CCO of SGD Pharma since October 2015, leading sales & marketing activities, as well as the trading company Embelia. Laurent joined the Commercial division of SGD Group (Perfumery and Pharmacy) in 2006, and defined the pharmacy strategy to further extend SGD’s leading position with stronger market shares in all segments. From 2010 to 2014, Laurent focused mainly on sales and operational performance resulting in a significant EBITDA increase. Laurent Zuber Started his career with Saint-Gobain Emballage (now Verralia), where he occupied various positions before he became Sales and Marketing VP of the containers division in 2002. He graduated from the Institut Supérieur de Commerce of Paris (France).